Epidemiology of hospitalizations attributable to Bordetella pertussis infection in the general population in Spain (1999-2005);Epidemiología de las hospitalizaciones atribuibles a infección por Bordetella pertussis en población general en España (1999-2005)

Vacunas

Volumn 9, Issue 2, 2008, Pages 50-56

  Santos, J M ^a   Gil, R ^a   Alvaro A ^a   Gil, A ^a  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

Author keywords

Bordetella pertussis; Hospitalization; Vaccines

Indexed keywords

EID: 70349629877     PISSN: 15769887     EISSN: 15788857     Source Type: Journal    
DOI: 10.1016/S1576-9887(08)72493-2     Document Type: Article

References (30)

1. Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med. 1996;334:349-55.
2. Wirsing von Konig CH, Postels-Multani S, Bock HL, Schmitt HJ. Pertussis in adults: frequency of transmission after household exposure. Lancet. 1995;346:1326-9.
3. Halperin SA. The control of pertussis-2007 and beyond. N Engl J Med. 2007;356:110-3.
4. a ed. Madrid: Acindes; 2007. p. 1411-36.
5. Rendi-Wagner P, Kundi M, Mikolasek A, Vecsei A, Fruhwirth M, Kollaritsch H. Hospital-based active surveillance of childhood pertussis in Austria from 1996 to 2003: estimates of incidence and vaccine effectiveness of wholecell and acellular vaccine. Vaccine. 2006;24:5960-5.
6. Campins M, Moraga F. Vacunación frente a la tos ferina en el adolescente y el adulto. Enferm Infecc Microbiol Clin. 2008;26:12-9.
7. Kowalzik F, Barbosa AP, Fernandes VR, et al. Prospective multinational study of pertussis infection in hospitalized infants and their household contacts. Pediatr Infect Dis J. 2007;26:238-42.
8. Keitel WA. Cellular and acellular pertussis vaccines in adults. Clin Infect Dis. 1999;28 Suppl 2: S118-23.
9. Iskedjian M, Walker JH, Hemels ME. Economic evaluation of an extended acellular pertussis vaccine programme for adolescents in Ontario, Canada. Vaccine. 2004;22:4215-27.
10. Tozzi AE, Pandolfi E, Celentano LP, Massari M, Salmaso S, Ciofi degli Atti ML. Comparison of pertussis surveillance systems in Europe. Vaccine. 2007;25:291-7.
11. Cromer BA, Goydos J, Hackell J, Mezzatesta J, Dekker C, Mortimer EA. Unrecognized pertussis infection in adolescents. Am J Dis Child. 1993;147:575-7.
12. Nennig ME, Shinefield HR, Edwards KM, Black SB, Fireman BH. Prevalence and incidence of adult pertussis in an urban population. JAMA. 1996;275:1672-4.
13. Sutter RW, Cochi SL. Pertussis hospitalizations and mortality in the United States, 1985-1988. Evaluation of the completeness of national reporting. JAMA. 1992;267:386-91.
14. Vera I, García-Comas L, Ordobas M, Gutiérrez A, Sanz JC, Barranco D. Incidence trends in pertussis in the Autonomous Region of Madrid, Spain: 1982-2005. Euro Surveill. 2007;12: E7-E8.
15. Stojanov S, Liese J, Belohradsky BH. Hospitalization and complications in children under 2 years of age with Bordetella pertussis infection. Infection. 2000;28:106-10.
16. Grant CC, Roberts M, Scragg R, et al. Delayed immunisation and risk of pertussis in infants: unmatched case-control study. BMJ. 2003;326:852-3.
17. Elliott E, McIntyre P, Ridley G, et al. National study of infants hospitalized with pertussis in the acellular vaccine era. Pediatr Infect Dis J. 2004;23:246-52.
18. Rendi-Wagner P, Paulke-Korinek M, Stanek G, Khanakah G, Kollaritsch H. Impact of a pertussis booster vaccination program in adolescents and adults on the epidemiology of pertussis in Austria. Pediatr Infect Dis J. 2007;26:806-10.
19. Cortese MM, Baughman AL, Brown K, Srivastava P. A "new age" in pertussis prevention new opportunities through adult vaccination. Am J Prev Med. 2007;32:177-85.
20. Kolos V, Menzies R, McIntyre P. Higher pertussis hospitalization rates in indigenous Australian infants, and delayed vaccination. Vaccine. 2007;25:588-90.
21. Visser LE, Cano PR, Gay NJ, Martínez Navarro JF. Impact of rotavirus disease in Spain: an estimate of hospital admissions due to rotavirus. Acta Paediatr Suppl. 1999;88:72-6.
22. Ministerio de Sanidad y Consumo. Clasificación internacional de enfermedades 9 revisión, modificación clínica; 1994.
23. Instituto Nacional de la Salud. Subdirección General de Coordinación Administrativa. Conjunto Mínimo Básico de Datos. Hospitales del INSALUD 2001. Madrid, 2002.
24. Rivero Cuadrado A. El conjunto mínimo básico de datos en el SNS: inicios y desarrollo actual. Rev Fuentes Estadísticas. 2000;49:18-9.
25. Faverau F. Healthcare Handbook. Vol. 4.2 Spain; 1998-1999. Lagon; F. Faverau Associates editors; 1998. p. 105-24.
26. Reverte-Cejudo D, Sánchez-Bayle M. Devolving health services to Spain's autonomous regions. BMJ. 1999;318:1204-5.
27. Gil A, Oyaguez I, Carrasco P, González A. Hospital admissions for pertussis in Spain, 1995-1998. Vaccine. 2001;19:4791-4. (Pubitemid 32800765)
28. Briand V, Bonmarin I, Levy-Bruhl D. Study of the risk factors for severe childhood pertussis based on hospital surveillance data. Vaccine. 2007;25:7224-32.
29. Moraga F, Roca J, Méndez C, et al. Epidemiology and surveillance of pertussis among infants in Catalonia, Spain, during 1997-2001. Pediatr Infect Dis J. 2005;24:510-3.
30. O'Brien JA, Caro JJ. Hospitalization for pertussis: profiles and case costs by age. BMC Infect Dis. 2005;5:57.